Status:
COMPLETED
The Use of Prophylactic Antibiotics In the Management of Dog Bites
Lead Sponsor:
Stanford University
Collaborating Sponsors:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Conditions:
Bite
Wound
Eligibility:
All Genders
Phase:
PHASE2
PHASE3
Brief Summary
This double blinded RCT will help to ascertain the usefulness of prophylactic antibiotics in the management of uncomplicated dog bites, utilizing currently best available antibiotics (Augmentin) and a...
Detailed Description
This double blinded RCT will help to ascertain the usefulness of prophylactic antibiotics in the management of uncomplicated dog bites, utilizing currently best available antibiotics (Augmentin) and a...
Eligibility Criteria
Inclusion
- All patients including all children and English speaking/reading persons who present with a full thickness dog bite to participating emergency departments will be considered. Non-English speaking/reading subjects for whom we can provide translation for will also be considered.
Exclusion
Key Trial Info
Start Date :
August 1 2003
Trial Type :
INTERVENTIONAL
End Date :
November 1 2005
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT00185939
Start Date
August 1 2003
End Date
November 1 2005
Last Update
December 5 2006
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Mills Peninsula Hospital
Burlingame, California, United States
2
UCSF Medical Center
San Francisco, California, United States, 94143
3
Stanford University Medical Center
Stanford, California, United States, 94305